GlassScriptPhysician profile
Brian K Hogan
NPI 1679677298
$123,459.88
in general payments reported to CMS, 2019-2025
80 companies · $4,940 in 2025
The $4,940 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $11K · 2021: $26K · 2022: $27K · 2023: $14K · 2024: $15K · 2025: $4,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $13K · Consulting Fee: $1,520 · Travel and Lodging: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,018.75 |
| Food and Beverage | $13,468.45 |
| Consulting Fee | $1,520.00 |
| Travel and Lodging | $260.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25,209.48 | 2021-2025 | |
| Amgen INC. | $23,912.56 | 2019-2025 | Uplizna |
| Biohaven Pharmaceutical Holding Company LTD. | $20,500.68 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20,047.43 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $12,603.44 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $2,908.49 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Biogen, INC. | $1,708.13 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Pfizer INC. | $1,203.52 | 2019-2025 | |
| Csl Behring | $1,003.34 | 2020-2025 | Hizentra |
| Novartis Pharmaceuticals Corporation | $821.65 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $709.82 | 2019-2025 | Ingrezza, Ongentys |
| Eisai INC. | $680.73 | 2019-2025 | |
| Genentech USA, INC. | $599.34 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Alexion Pharmaceuticals, INC. | $580.34 | 2019-2025 | Ultomiris, Soliris |
| Sk Life Science, INC. | $569.94 | 2020-2025 | Xcopri |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $484.54 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Lundbeck LLC | $470.65 | 2019-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $457.10 | 2019-2025 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $453.42 | 2023-2025 | Rexulti, Nuedexta |
| Grifols USA, LLC | $429.74 | 2019-2025 | Gamunex-C |
| Horizon Therapeutics Plc | $418.96 | 2021-2023 | Uplizna |
| Catalyst Pharmaceuticals, INC. | $414.65 | 2020-2025 | Firdapse, Fycompa |
| Argenx US, INC. | $407.99 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Allergan, INC. | $392.53 | 2019-2022 | |
| Neurelis, INC. | $375.36 | 2020-2025 | Valtoco |
| Merz Pharmaceuticals, LLC | $366.31 | 2021-2025 | Xeomin, Ampyra, Inbrija |
| Ipsen Biopharmaceuticals, INC | $331.68 | 2019-2025 | Dysport |
| Emd Serono, INC. | $327.32 | 2019-2025 | Mavenclad |
| Kyowa Kirin, INC. | $311.18 | 2019-2025 | Nourianz |
| Upsher-Smith Laboratories LLC | $304.00 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $278.79 | 2022-2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $244.03 | 2020-2025 | Hyqvia, Trintellix, Gammagard |
| Acorda Therapeutics, INC | $231.04 | 2019-2024 | Inbrija, Ampyra |
| Genzyme Corporation | $219.19 | 2019-2025 | |
| Celgene Corporation | $208.71 | 2021-2025 | Zeposia |
| Adamas Pharmaceuticals, INC. | $198.51 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $192.38 | 2019-2025 | |
| Tanabe Pharma America, INC. | $182.01 | 2019-2025 | Radicava |
| Greenwich Biosciences, INC. | $173.42 | 2019-2021 | |
| Tg Therapeutics, INC. | $171.09 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $169.20 | 2021-2024 | Qelbree |
| Amneal Pharmaceuticals LLC | $165.41 | 2019-2025 | Rytary, Crexont |
| Avanir Pharmaceuticals, INC. | $155.37 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $137.54 | 2021-2022 | |
| Akcea Therapeutics, INC. | $137.38 | 2019-2021 | |
| Aucta Pharmaceuticals, INC. | $106.28 | 2024-2025 | Motpoly Xr |
| Mdd US Operations, LLC | $104.02 | 2019-2025 | Gocovri, Qelbree |
| Aquestive Therapeutics, INC. | $98.66 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $92.82 | 2021-2024 | Ztlido |
| Xeris Pharmaceuticals, INC. | $88.16 | 2022-2025 | Keveyis |
| Janssen Biotech, INC. | $79.26 | 2025 | |
| Alnylam Pharmaceuticals INC. | $71.17 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $67.06 | 2024-2025 | Ponvory |
| Averitas Pharma INC. | $65.60 | 2023-2024 | Qutenza |
| Impel Pharmaceuticals INC. | $61.99 | 2023 | Trudhesa |
| Astrazeneca Pharmaceuticals LP | $60.24 | 2021-2025 | Wainua |
| Inspire Medical Systems, INC. | $56.03 | 2025 | Inspire |
| Harmony Biosciences LLC | $53.85 | 2020-2021 | |
| Strongbridge US INC. | $53.42 | 2019-2020 | |
| Axsome Therapeutics, INC. | $47.43 | 2023-2025 | Sunosi |
| Zyla Life Sciences, INC. | $46.52 | 2019 | |
| Ge Healthcare | $41.78 | 2020-2025 | |
| Assertio Therapeutics, INC. | $40.93 | 2019-2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $35.70 | 2025 | Rexulti |
| Mallinckrodt Hospital Products INC. | $33.94 | 2021 | |
| Avion Pharmaceuticals | $30.76 | 2022 | |
| Merz North America, INC. | $28.44 | 2020 | |
| Arbor Pharmaceuticals, INC. | $27.16 | 2019-2020 | |
| Livanova USA, INC. | $25.72 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Pharmacosmos Therapeutics INC. | $22.72 | 2023 | Monoferric |
| Merck Sharp & Dohme LLC | $21.25 | 2021 | |
| Boston Scientific Corporation | $18.04 | 2019 | |
| Resmed Corp | $15.35 | 2025 | |
| Monteris Medical Corporation | $15.17 | 2025 | Neuroblate |
| Kedrion Biopharma, INC. | $15.11 | 2024 | Gammaked, Koate, Kedrab |
| Amylyx Pharmaceuticals, INC. | $14.17 | 2023 | Relyvrio |
| Zogenix INC. | $13.92 | 2021 | |
| Promius Pharma LLC | $13.69 | 2019 | |
| Medtronic, INC. | $12.91 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.